A detailed history of Moloney Securities Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 3,486 shares of NVS stock, worth $361,881. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,486
Previous 3,486 -0.0%
Holding current value
$361,881
Previous $371,000 7.82%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$92.57 - $107.37 $25,456 - $29,526
-275 Reduced 7.31%
3,486 $371,000
Q1 2024

May 01, 2024

BUY
$95.27 - $108.47 $38,584 - $43,930
405 Added 12.07%
3,761 $363,000
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $73,908 - $81,333
801 Added 31.35%
3,356 $338,000
Q3 2023

Oct 31, 2023

SELL
$94.73 - $105.13 $50,017 - $55,508
-528 Reduced 17.13%
2,555 $260,000
Q2 2023

Jul 31, 2023

SELL
$92.52 - $104.91 $356,202 - $403,903
-3,850 Reduced 55.53%
3,083 $311,000
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $28,010 - $32,483
-350 Reduced 4.81%
6,933 $637,000
Q4 2022

Jan 30, 2023

BUY
$75.55 - $92.52 $113,325 - $138,780
1,500 Added 25.94%
7,283 $660,000
Q3 2022

Oct 31, 2022

SELL
$74.61 - $87.26 $2,611 - $3,054
-35 Reduced 0.6%
5,783 $440,000
Q2 2022

Aug 03, 2022

BUY
$80.52 - $93.75 $8,937 - $10,406
111 Added 1.94%
5,818 $492,000
Q1 2022

May 10, 2022

SELL
$80.11 - $90.62 $3,604 - $4,077
-45 Reduced 0.78%
5,707 $501,000
Q4 2021

Jan 28, 2022

SELL
$79.7 - $88.13 $105,124 - $116,243
-1,319 Reduced 18.65%
5,752 $503,000
Q3 2021

Oct 27, 2021

SELL
$81.78 - $95.14 $3,434 - $3,995
-42 Reduced 0.59%
7,071 $578,000
Q2 2021

Jul 26, 2021

SELL
$85.24 - $94.15 $62,225 - $68,729
-730 Reduced 9.31%
7,113 $649,000
Q1 2021

Apr 28, 2021

SELL
$83.5 - $98.47 $9,185 - $10,831
-110 Reduced 1.38%
7,843 $670,000
Q4 2020

Feb 08, 2021

SELL
$78.07 - $94.43 $335,700 - $406,049
-4,300 Reduced 35.09%
7,953 $751,000
Q3 2020

Oct 20, 2020

SELL
$82.14 - $91.0 $9,446 - $10,465
-115 Reduced 0.93%
12,253 $1.07 Million
Q2 2020

Jul 31, 2020

SELL
$80.93 - $91.1 $20,232 - $22,775
-250 Reduced 1.98%
12,368 $1.08 Million
Q1 2020

May 08, 2020

BUY
$70.67 - $99.01 $88,408 - $123,861
1,251 Added 11.01%
12,618 $1.04 Million
Q4 2019

Feb 06, 2020

SELL
$84.35 - $95.37 $1,602 - $1,812
-19 Reduced 0.17%
11,367 $1.08 Million
Q3 2019

Nov 01, 2019

BUY
$85.54 - $94.26 $76,986 - $84,834
900 Added 8.58%
11,386 $989,000
Q2 2019

Jul 29, 2019

SELL
$75.4 - $92.8 $62,657 - $77,116
-831 Reduced 7.34%
10,486 $958,000
Q1 2019

May 03, 2019

BUY
$75.32 - $86.15 $256,991 - $293,943
3,412 Added 43.16%
11,317 $1.09 Million
Q4 2018

Feb 11, 2019

BUY
$73.66 - $82.02 $25,928 - $28,871
352 Added 4.66%
7,905 $678,000
Q3 2018

Oct 24, 2018

BUY
$66.94 - $77.43 $2,476 - $2,864
37 Added 0.49%
7,553 $0
Q2 2018

Jul 26, 2018

SELL
$64.91 - $73.36 $181,942 - $205,628
-2,803 Reduced 27.16%
7,516 $568,000
Q1 2018

Apr 25, 2018

BUY
$70.39 - $84.15 $405,094 - $484,283
5,755 Added 126.1%
10,319 $834,000
Q4 2017

Jan 25, 2018

BUY
$72.33 - $77.64 $122,093 - $131,056
1,688 Added 58.69%
4,564 $383,000
Q3 2017

Oct 18, 2017

BUY
$74.14 - $77.27 $213,226 - $222,228
2,876
2,876 $247,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.